Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cemiplimab
Related studies linked through entity extraction aliases.
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TOP 2301: Neoadjuvant Chemo for NSCLC
- Status
- SUSPENDED
- Phase
- PHASE2
Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Status
- RECRUITING
- Phase
- PHASE3
Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access Use of Cemiplimab in Patients With Solid Tumors
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1